Biotechnology Stocks II Performance Guide: Novavax, Inc. (NVAX)
NVAX has no dividends.
Table and Chart of NVAX Performance
See what a $1,000 investment in NVAX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NVAX Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $94.20 |
| End Date | May-16-2024 |
| End Price | $14.40 |
| # Prices | 121 |
| Min Date | Dec-31-2019 |
| Min Price | $3.98 |
| Max Date | Jul-31-2015 |
| Max Price | $241.20 |
| Total Return | -84.71% |
| Annualized Return | -16.99% |
| Current Value of $1,000 Purchase | $153 |
| Number Returns | 7,260 |
| Average Return | 114.05% |
| Number Profitable Returns | 2,484 |
| Percent Profitable Returns | 34.21% |
| Number Unprofitable Returns | 4,776 |
| Percent Unprofitable Returns | 65.79% |
| Profitable to Unprofitable Returns Ratio | 0.52 |
| NVAX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,900,144,000 |
| Beta | 1.620 | Price to Sales | 0.61 |
| Earnings per Share | $-3.0500 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 49.52 |
| PRICE DATA | |
| 52 Week High | $15 |
| 52 Week Low | $3.532 |
| Analyst Target Price | $18 |
| 50-Day Moving Average | $5.2 |
| 200-Day Moving Average | $5.9 |
| FINANCIAL DATA | |
| Revenue per Share | $8.73 |
| Revenue | $996,609,000 |
| Profit Margin | -40% |
| Return on Equity | -898% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NVAX Compare Returns with S&P 500
NVAX Trendline Chart
NVAX Moving Average Chart
NVAX Stock Return Map - See Patterns of Gains and Losses
NVAX Stock Returns/Purchase Dates